The significance of tumoral ERCC1 status in patients with locally advanced cervical cancer treated with chemoradiation therapy: A multicenter clinicopathologic analysis

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 3, 2013, Pages 721-727

  Doll, Corinne M ^a   Aquino Parsons, Christina ^b   Pintilie, Melania ^c   Klimowicz, Alexander C ^a   Petrillo, Stephanie K ^a   Milosevic, Michael ^d   Craighead, Peter S ^a   Clarke, Blaise ^e   Lees Miller, Susan P ^f   Fyles, Anthony W ^d   Magliocco, Anthony M ^g  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERVICAL CANCERS; CHEMORADIATION; CIS-PLATIN; CLINICAL OUTCOME; EXCISION REPAIR; INTERNATIONAL FEDERATION; MOLECULAR MARKER; MULTI VARIATE ANALYSIS; OVERALL SURVIVAL; PRE-TREATMENT; PROGRESSION FREE SURVIVAL; TISSUE MICROARRAYS; TUMOR SITE; TUMOR SIZE; UNIVARIATE ANALYSIS;

CHEMORADIOTHERAPY; FORMALDEHYDE; HEMOGLOBIN; MULTIVARIANT ANALYSIS; PARAFFINS; PATIENT MONITORING; PLATINUM COMPOUNDS;

TUMORS;

ANTINEOPLASTIC AGENT; CESIUM; CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FL297 POLYCLONAL ANTIBODY; FORMALDEHYDE; PARAFFIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CANADA; CANCER LOCALIZATION; CANCER PATIENT; CANCER TISSUE; CHEMORADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EMBEDDING; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HAZARD RATIO; HUMAN; LOCALLY ADVANCED CERVICAL CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK FACTOR; TISSUE MICROARRAY; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CANCER;

ANALYSIS OF VARIANCE; CELL NUCLEUS; CHEMORADIOTHERAPY; CYTOPLASM; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 84873315587     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.06.021     Document Type: Article

References (20)

1. J. Ferlay, H.-R. Shin, and F. Bray Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. C. Vale, J.F. Tierney, L.A. Stewart Chemoradiotherapy for cervical cancer meta-analysis collaboration Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials J Clin Oncol 26 2008 5802 5812
3. R. Poetter, P. George, and J.C.A. Dimopoulos Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer Radiother Oncol 100 1 2011 116 123
4. C. Haie-Meder, R. Poetter, and E. Van Limbergen Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image-based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV Radiother Oncol 74 2005 235 245
5. R. Poetter, C. Haie-Meder, and E. Van Limbergen Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77
6. L. Gossage, and S. Madhusudan Current status of excision repair cross complementing-group 1 (ERCC1) in cancer Cancer Treat Rev 33 6 2007 565 577
7. G.R. Adair, R.L. Rolig, and D. Moore-Faver Role of ERCC1 in removal of long non-homologous tails during targeted homologous recombination EMBO J 19 20 2000 5552 5561
8. A. Ahmad, A.R. Robinson, and A. Duensing ERCC1-XPF endonuclease facilitates DNA double-strand break repair Mol Cell Biol 28 16 2008 5082 5092
9. H.J. Jun, M.J. Ahn, and H.S. Kim ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation Br J Cancer 99 1 2008 167 172
10. S.H. Chan, F.M. Cheung, and W.T. Ng Can the analysis of ERCC1 expression contribute to individualized therapy in nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 79 5 2011 1414 1420
11. U. Warnecke-Eberz, R. Metzger, and F. Miyazono High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer Clin Cancer Res 10 11 2004 3794 3799
12. M.K. Kim, K.-J. Cho, and G.Y. Kwon ERCC1 predicting chemoradiation resistance and poor outcome in esophageal cancer Eur J Cancer 44 2008 54 60
13. R.A. Britten, D. Liu, and A. Tessier ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells Int J Cancer 89 5 2000 453 457
14. J.-S. Park, E.K. Jeon, and S.H. Chun ERCC1 (excision repair cross-complementation group 1) expression as a predictor for response of neoadjuvant chemotherapy for stage 2B uterine cervix cancer Gynecol Oncol 120 2011 275 279
15. Z.L. Liang, E.-K. Song, and Y.B. Ko Excision repair cross-complementation group 1 expression predicts response and survival in locally advanced cervical carcinoma patients treated with concurrent chemoradiotherapy Histopathology 59 3 2011 564 567
16. C.M. Doll, M. Prystajecky, and M. Eliasziw Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone Radiother Oncol 97 2 2010 352 359
17. L.J. Niedernhofer, N. Bhagwat, and R.D. Wood ERCC1 and non-small-cell lung cancer N Engl J Med 356 24 2007 2538 2540
18. N.R. Bhagwat, V.Y. Roginskaya, and M.B. Acquafondata Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue Cancer Res 69 17 2009 6831 6838
19. R.L. Camp, G.G. Chung, and D.L. Rimm Automated subcellular localization and quantification of protein expression in tissue microarrays Nat Med 8 11 2002 1323 1327
20. G.R. Simon, R. Ismail-Khan, and G. Bepler Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality Int J Biochem Cell Biol 39 2007 1318 1328